FDA ANDA · ANDA211598
VORICONAZOLE
Sponsor: HETERO LABS LTD V
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA211598
TYPE
ANDA
ORIGINAL APPROVAL
2025-08-08
LATEST ACTION
2026-10-19
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Prescription
Products
VORICONAZOLEPrescription
VORICONAZOLE 200MG/5ML · FOR SUSPENSION · ORAL
Approval history
2026-10-19Labeling · Supplement 3 · standardAP
2025-08-08UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →